Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Sputum inflammatory cells</td><td align="center"> </td></tr><tr><td align="left"> Neutrophils, median (range), %</td><td align="center">79.3 (1.5–98.1)</td></tr><tr><td align="left"> Eosinophils, median (range), %</td><td align="center">0.8 (0–70.2)</td></tr><tr><td align="left">Exhaled NO, ppb</td><td align="center">22.5 (2–168)</td></tr><tr><td align="left">MDA (EBC), nM</td><td align="center">30.4 (6–116)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Biomarkers measured in the sputum, EBC, and exhaled air in the examined patients with NCFB.

Mediators of Inflammation

tab2

Table 2

Table 2: Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis 